Back to investors
PARADIGM BIOCAPITAL ADVISORS LP
PARADIGM BIOCAPITAL ADVISORS LP
Latest filing: 2026-06-30
PARADIGM BIOCAPITAL ADVISORS LP runs PARADIGM BIOCAPITAL ADVISORS LP and currently holds 28 stock positions, which is fewer than the average of 230 among the investors we track. The portfolio is valued at approximately $5.34B. Their top holdings are RVMD, NUVL, EWTX, GMAB, SYRE. The top five represent 56.9% of reported portfolio weight. PARADIGM BIOCAPITAL ADVISORS LP ranks #N/A out of 1000 investors tracked by Alpha Score. In the most recent quarter, PARADIGM BIOCAPITAL ADVISORS LP initiated 5 new positions. They added to 10 existing positions. They trimmed 6 positions. Their current best-performing preview position is ORKA with returns of +94.03%.
Sign in to enable email alerts for this investor.
Showper page
28 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 RVMD REVOLUTION MEDICINES INC | 22.31% | $39.65 | $209.46 | +428.27% | Trimmed -4.42% |
 NUVL NUVALENT INC | 13.70% | $73.34 | $123.96 | +69.02% | Added +11.27% |
 EWTX EDGEWISE THERAPEUTICS INC | 7.77% | $26.62 | $44.18 | +65.97% | Added +38.70% |
 GMAB GENMAB A/S | 6.76% | $29.17 | $33.45 | +14.67% | Added +64.83% |
 SYRE SPYRE THERAPEUTICS INC | 6.38% | $59.49 | $106.49 | +79.00% | Added +96.23% |
 APGE APOGEE THERAPEUTICS INC | 3.92% | $66.06 | $134.75 | +103.98% | Added +16.92% |
 ORKA ORUKA THERAPEUTICS INC | 3.82% | $35.24 | $107.96 | +206.36% | Trimmed -7.58% |
 TNGX TANGO THERAPEUTICS INC | 3.72% | $24.74 | $23.88 | -3.48% | Added +58.55% |
 ERAS ERASCA INC | 3.28% | $2.44 | $17.63 | +622.54% | Trimmed -8.11% |
 TARS TARSUS PHARMACEUTICALS INC | 3.27% | $35.17 | $72.70 | +106.71% | Added +8.33% |
Showing 1-10 of 28